Xeris Pharmaceuticals Inc Stock, NASDAQ:XERS
180 North LaSalle Street, Suite 1600, Chicago, Illinois 60601
United States of America
Number of Employees: 180
Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.